A Note about COVID-19

Over the last few months, Roche, alongside our partners, has been monitoring the global spread of the novel coronavirus (COVID-19) and is working closely with healthcare providers and patient communities to better understand the impact of this pandemic on the patients that are part of our clinical studies and their families.

We understand that, as individuals living with a medical condition, you are likely facing a higher level of uncertainty and anxiety during this pandemic. We want to reinforce that patient safety is a critical priority for Roche. We recognise that you likely have questions about your continued participation in our study and may be wondering how we, as a company, plan to support you during this time. READ MORE

ForPatients

ForPatients is an informational resource for patients, their relatives, caregivers or doctors looking for information in clear and simple language about clinical trials or diseases where Roche/Genentech is doing research or supporting research conducted by others. READ MORE

Finn et al. N Engl J Med 2020

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma READ MORE

Lee et al. Lancet Oncol 2020

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study READ MORE